Skip to main content
Premium Trial:

Request an Annual Quote

Avesthagen to Use Affymetrix Microarrays in Parsi Study

NEW YORK (GenomeWeb News) – Affymetrix said today that Avesthagen will use its microarrays in a genetic study of the Parsi-Zoroastrian population.
 
Bangalore, India-based Avesthagen plans to conduct a study, called the AvestaGenome Project, of more than 60,000 Parsi individuals in an effort to reveal the genetic basis of longevity among that population. According to the companies, 31 percent of the Parsi population lives beyond the age of 60 compared to 7 percent nationally in India.
 
Avesthagen researchers intend to correlate genes with longevity, as well as neurodegenerative conditions, breast cancer, diabetes, and other complex diseases in the Parsi community.
 
The genotyping phase of the project began in October 2007. By the middle of this year, Avesthagen plans to perform gene expression profiling and transcript mapping experiments across a subset of samples. The project is scheduled to finish by 2013.
 
Financial terms of the agreement were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.